IRadimed CorporationIRMDNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
3.88%
↑ 34% above average
Average (39q)
2.89%
Historical baseline
Range
High:17.84%
Low:-22.25%
CAGR
-1.6%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 3.88% |
| Q2 2025 | 4.61% |
| Q1 2025 | 0.63% |
| Q4 2024 | 5.80% |
| Q3 2024 | 2.21% |
| Q2 2024 | 1.88% |
| Q1 2024 | 0.84% |
| Q4 2023 | 5.74% |
| Q3 2023 | 2.32% |
| Q2 2023 | 4.23% |
| Q1 2023 | 4.11% |
| Q4 2022 | 10.86% |
| Q3 2022 | 5.39% |
| Q2 2022 | 3.34% |
| Q1 2022 | 3.69% |
| Q4 2021 | 8.85% |
| Q3 2021 | 11.18% |
| Q2 2021 | 6.36% |
| Q1 2021 | 7.93% |
| Q4 2020 | 11.00% |
| Q3 2020 | 13.31% |
| Q2 2020 | -21.70% |
| Q1 2020 | -20.32% |
| Q4 2019 | 9.31% |
| Q3 2019 | 8.00% |
| Q2 2019 | 9.34% |
| Q1 2019 | 1.18% |
| Q4 2018 | 9.52% |
| Q3 2018 | 3.22% |
| Q2 2018 | 3.78% |
| Q1 2018 | 6.01% |
| Q4 2017 | 17.84% |
| Q3 2017 | 2.99% |
| Q2 2017 | 7.01% |
| Q1 2017 | -13.82% |
| Q4 2016 | -21.93% |
| Q3 2016 | -22.25% |
| Q2 2016 | 10.09% |
| Q1 2016 | 1.87% |
| Q4 2015 | 7.39% |